γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant

Summary

This is a prospective, double-arm, single-center, randomized controlled single-blind clinical study

Timeline

Start

2025-09-01

Primary completion

2028-05-30

Completion

2028-05-30

Drugs

Indications